Helping Hand Program for Osteoarthritis
("Helping Hand" Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines a new online program designed to help manage hand osteoarthritis. It aims to determine whether participants find the program useful and easy to follow, rather than testing its effectiveness. Participants will either try the new Helping Hand - Joint Protection Program or continue with their usual care for 12 weeks. Suitable candidates have experienced hand osteoarthritis with pain for at least three months and can use a smartphone, tablet, or computer. As an unphased trial, this study allows participants to contribute to research that could enhance future care options for hand osteoarthritis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems you can continue your usual care, which may include your current medications.
What prior data suggests that the Helping Hand Joint Protection Program is safe for hand osteoarthritis?
Research has shown that the Helping Hand - Joint Protection Program for hand osteoarthritis (a type of arthritis affecting the hands) is generally safe. A thorough review found no specific safety concerns, suggesting it is well-tolerated. Participants in similar studies did not report major negative side effects, indicating the program's safety. This program mainly includes online information, activities, and support, making it low-risk. While it may not offer significant benefits, it does not pose safety issues.12345
Why are researchers excited about this trial?
Researchers are excited about the Helping Hand - Joint Protection Program for osteoarthritis because it offers a fresh, comprehensive approach to managing hand osteoarthritis beyond standard care options like medications and physical therapy. Unlike typical treatments, this program is divided into six interactive modules combining educational content and community support, which helps patients learn practical strategies for daily living and managing their condition. A standout feature is the live community of practice sessions, allowing participants to share experiences and learn directly from peers and clinicians, fostering a supportive environment that standard treatments typically lack.
What evidence suggests that the Helping Hand Joint Protection Program is effective for hand osteoarthritis?
Research has shown that joint protection programs can help people with hand osteoarthritis by reducing pain and improving hand function. A review of various studies found that programs combining joint protection with other methods effectively ease pain and enhance hand function for those with this condition. However, some studies suggest the benefits might not always be very noticeable. In this trial, participants will either receive the Helping Hand - Joint Protection Program or be placed on a waitlist to initially receive standard care. It is important to note that the Helping Hand program is still under evaluation, so further research is needed to determine its effectiveness.678910
Are You a Good Fit for This Trial?
This trial is for individuals with hand osteoarthritis who have been in pain for at least three months. Participants must be able to use digital devices and communicate in English. It's not suitable for those planning hand surgery soon or with neurological disorders, dementia, or cognitive conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants gain access to an online Joint Protection Program or continue to receive usual care for 12 weeks
Follow-up
Participants are monitored for adherence and acceptability of the Joint Protection Program
What Are the Treatments Tested in This Trial?
Interventions
- Helping Hand - Joint Protection Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
The Arthritis Society, Canada
Collaborator